Skip to main content
. 2018 Jul 30;18(9):259–264. doi: 10.1016/j.bjae.2018.05.007

Table 6.

American College of Cardiology summary of available reversal agents and suggested use.21 aPCC, activated PCC; 4F-PCC, four-factor PCC

Reversal agent Vitamin K antagonist (warfarin) Factor IIa inhibitor (dabigatran) Factor Xa inhibitor (apixaban, edoxaban, and rivaroxaban)
4F-PCC First line Second line First line
aPCC Not indicated Second line Second line
Idarucizumab Not Indicated First line Not indicated
Plasma If 4-PCC is unavailable Not indicated Not indicated